Sign in
4

Changes in Ownership

Immunome Inc. Filed Acc 0001831215-26-000005

CHIEF BUSINESS OFFICER sold 90,616 shares at $25.09 ($2,273,555)

  • CHIEF BUSINESS OFFICER acquired 90,616 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Horn Kinney · CHIEF BUSINESS OFFICER

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-04 Exercise or conversion : show line 1 in the form 10b5-1 +50,366 $12.92 $650,729 50,366 D
2026-08-04 Exercise or conversion : show line 2 in the form 10b5-1 +40,250 $10.60 $426,650 90,616 D
2026-08-04 Sale : show line 3 in the form 10b5-1 −90,616 $25.09 $2,273,555 0 D
Open-market sales · 90,616 sh · avg $25.09 · $2,273,555

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-08-04 Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (right to buy) −50,366 78,542 D
2026-08-04 Exercise or conversion : show line 5 in the form 10b5-1 Employee Stock Option (right to buy) −40,250 120,750 D
Loading xslF345X06/form4-08062026_100833.xml…